every company makes mistakes. and that is not to say that AMBS will get their long awaited JV. I am predicting that calpain inhibitors, the next step in the apoptosis process will win out.
Did you get a chance to read those patents. Chances are the compound that Fumi is now using ( which is not MANF ) is already patented. That is the first thing that you do when you make a compound. Calpain being a protease, we have been using protease inhibitors in the clinic for 30 years.
News 
Market Data 
Discover 
AI
